Advarra

Let us know if we'll see you in June! ☀ 📍 May 31 - June 4: ASCO 2024 (Chicago, IL) https://lnkd.in/d9ZnEEG 📍 June 5-7: Pharmaceutical Contract Management Group Assembly 2024 (Den Haag, Netherlands) https://lnkd.in/ePXKy4cj 📍 June 10-12: HCCA Research Compliance Conference (New Orleans, LA) https://lnkd.in/gjSw-K8d Join us for Advarra Chairperson Cheri Pettey's session on Tuesday, June 11 at 2:15pm – Data Sharing: Ethical and Practical Considerations for Institutions 📍 June 16-20: DIA Global 2024 (San Diego, CA) https://lnkd.in/djGtmvtD

Sponsors are turning to technology to improve efficiency and streamline workflows. While technology is having a positive impact on trials (accelerating the collection of higher quality data, for example), its introduction into clinical trial settings has resulted in unforeseen burdens on sites. In a recent article for ACRP - Association of Clinical Research Professionals, our Chief Product Officer Elisa Cascade shares findings from Advarra's 2023 Study Activation Survey Report, which revealed that a typical oncology study now uses about 22 (yes, 22!) different systems. Sites are already dealing with substantial administrative burdens, and with nearly two-thirds of respondents in Advarra’s survey reporting that the burden caused by technology is far greater than it was just five years ago, dealing with training, onboarding, and management on 22 different systems just isn't feasible. Elisa shares her insights around what we can do to navigate this challenge here: https://lnkd.in/gn7xbsBY #ClinicalResearch #ClinicalTrials #HealthcareTechnology #HealthcareInnovation

This past weekend, Advarra was proud to sponsor the India Society for Clinical Research (ISCR) Run 4 Research! 👟🏃 Run 4 Research raises awareness for clinical research in India, and plays a vital role in developing new treatments, medications, and technologies that save lives and improve patient outcomes across the country. Our team had such a blast participating this year – we're grateful to support groundbreaking research that continues to pave the way for the future of healthcare in India and beyond. Learn more about ISCR and Run 4 Research here: https://lnkd.in/gB2icb9E #ClinicalTrials #ClinicalResearch #HealthcareInnovation

Team Advarra at the “Run 4 Research” organised by the Indian Society for Clinical Research. ✨ A joyous Sunday morning bringing the research and the running fraternity together, raising awareness of the significance of clinical research and its role in bringing much need therapies and treatments to patients world over. A common thread that binds the industry together is the passion for what we do requiring us to work tirelessly, often racing against time yet ensuring highest standards of quality. It does come with the down side of us being tied down to our work desks majority of our days. Initiatives encouraging fitness and making it a part of our daily routine is sacrosanct to our well being, especially in the times we live in today. Thank you ISCR for the wonderful initiative, giving us an opportunity to sponsor and participate in the event! Indian Society for Clinical Research #Run4Reserach #Advarra Orla Mester, MBA, MSMIS, PMP, CSP Vinay Kumar (he/him) Dr. Eshmeet Singh Ajay Indrajit Mala Srivastava MRQA Thanuja Naidu Dr. Rajani I Menon Ami Shah (Parikh) Dr Ananya Chakraborty Lakshmi Achuta MRQA

Clinical trials may be expensive and slow, but according to Advarra's SVP of Site/Sponsor Innovation Christine Senn, PhD, we're on the precipice of change. One area that could accelerate trial execution (and reduce burden) is improving trial feasibility – the process by which a sponsor or CRO identifies trial sites. The current process is broken and those fractures have downstream effects that negatively impact every stakeholder. After all, burden leads to burnout, which directly impacts trial efficacy and patient experience. In a recent piece for The Medicine Maker, Christine shares eight uncomplicated dos and don'ts for improving feasibility. Read the full article here for more insights from Christine: https://lnkd.in/gKXZhNCj #ClinicalResearch #ClinicalTrials #HealthcareInnovation

A better trial experience for patients, sites, and study teams = better trial results. That's why over 12,000 sites have turned to Advarra Longboat's intuitive technology to accelerate the study lifecycle, optimize operations and compliance, and improve stakeholder collaboration. See why sites love Longboat: https://lnkd.in/gvT5z4uW #ClinicalResearch #ClinicalTrials #HealthcareInnovation

"There are 22 different systems that a site needs to log into on an oncology study. We have to find a way to make it simpler for them, and I see ACRP being that connector." Elisa Cascade, Chief Product Officer at Advarra, highlights a Clinical Researcher article published in the June 2024 edition which notes that U.S. clinical research is expanding due to new technologies, but faces challenges in patient recruitment and administrative burdens that could be eased by Single Sign-On solutions. Read more in "The Illness and the Cure: Technology is Indispensable in Clinical Research, But its Proliferation is Also Creating Friction" > https://bit.ly/3VUTlu2 #ClinicalResearcher #ClinicalTrials #ClinicalResearchTechnology #PatientRecruitment

Our Chief Growth Officer Bryan C. Spielman recently joined an Applied Clinical Trials Magazine roundtable to discuss the current state of sustainability in clinical research with fellow industry leaders. Check out the full article to read Bryan's insights on topics like the carbon footprint of research, the use of technology, reaching underrepresented populations in trials, and the clinical supply chain: https://lnkd.in/gQckdvTN #ClinicalTrials #ClinicalResearch #HealthcareInnovation #HealthcareSustainability

We had such an amazing time at #DIA2024 this year! Here's a little behind the scenes of our booth action + speaking sessions featuring Stuart Cotter, James Riddle, and Elisa Cascade. Until next time, DIA! 🛫 #ClinicalTrials #ClinicalResearch #HealthcareInnovation

Happy Juneteenth! Today at Advarra, we're honoring this important holiday and milestone in our country's history. We remain committed to diversity, equity, and inclusion within safe and ethical trials for all. Our U.S. offices will be closed today, Wednesday, June 19, in observance of Juneteenth.